Pluri Inc (PLUR)
4.560
-0.29
(-5.98%)
USD |
NASDAQ |
Nov 04, 16:00
4.85
+0.29
(+6.36%)
After-Hours: 20:00
Pluri Revenue (Quarterly): 0.096M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 0.096M |
March 31, 2024 | 0.071M |
December 31, 2023 | 0.105M |
September 30, 2023 | 0.054M |
June 30, 2023 | 0.111M |
March 31, 2023 | 0.087M |
December 31, 2022 | 0.002M |
September 30, 2022 | 0.087M |
June 30, 2022 | |
March 31, 2022 | 0.234M |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | 0.023M |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | 0.05M |
September 30, 2018 | 0.004M |
June 30, 2018 |
Date | Value |
---|---|
March 31, 2018 | |
December 31, 2017 | 0.05M |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | 2.752M |
September 30, 2015 | 0.095M |
June 30, 2015 | 0.094M |
March 31, 2015 | 0.095M |
December 31, 2014 | 0.095M |
September 30, 2014 | 0.095M |
June 30, 2014 | 0.094M |
March 31, 2014 | 0.095M |
December 31, 2013 | 0.095M |
September 30, 2013 | 0.095M |
June 30, 2013 | 0.095M |
March 31, 2013 | 0.194M |
December 31, 2012 | 0.195M |
September 30, 2012 | 0.195M |
June 30, 2012 | 0.101M |
March 31, 2012 | 0.23M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.002M
Minimum
Dec 2022
0.234M
Maximum
Mar 2022
0.087M
Average
0.087M
Median
Sep 2022
Revenue (Quarterly) Benchmarks
InspireMD Inc | 1.739M |
IDenta Corp | 0.361M |
BiomX Inc | -- |
IR-Med Inc | -- |
Raphael Pharmaceutical Inc | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -5.729M |
Total Expenses (Quarterly) | 6.13M |
EPS Diluted (Quarterly) | -1.07 |
Enterprise Value | 25.89M |
Profit Margin (Quarterly) | -5.97K% |
Earnings Yield | -82.47% |
Normalized Earnings Yield | -82.47 |